{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:32:40Z","timestamp":1792006360609,"version":"4.4.0"},"reference-count":52,"publisher":"American Diabetes Association","issue":"12","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,12,1]]},"abstract":"<jats:p>Akt is critical in insulin-induced metabolism of glucose and lipids. To investigate functions induced by hepatic Akt activation, a constitutively active Akt, NH2-terminally myristoylation signal-attached Akt (myr-Akt), was overexpressed in the liver by injecting its adenovirus into mice. Hepatic myr-Akt overexpression resulted in a markedly hypoglycemic, hypoinsulinemic, and hypertriglyceridemic phenotype with fatty liver and hepatomegaly. To elucidate the sterol regulatory element binding protein (SREBP)-1c contribution to these phenotypic features, myr-Akt adenovirus was injected into SREBP-1 knockout mice. myr-Akt overexpression induced hypoglycemia and hepatomegaly with triglyceride accumulation in SREBP-1 knockout mice to a degree similar to that in normal mice, whereas myr-Akt-induced hypertriglyceridemia in knockout mice was milder than that in normal mice. The myr-Akt-induced changes in glucokinase, phosphofructokinase, glucose-6-phosphatase, and PEPCK expressions were not affected by knocking out SREBP-1, whereas stearoyl-CoA desaturase 1 induction was completely inhibited in knockout mice. Constitutively active SREBP-1-overexpressing mice had fatty livers without hepatomegaly, hypoglycemia, or hypertriglyceridemia. Hepatic acetyl-CoA carboxylase, fatty acid synthase, stearoyl-CoA desaturase 1, and glucose-6-phosphate dehydrogenase expressions were significantly increased by overexpressing SREBP-1, whereas glucokinase, phospho-fructokinase, glucose-6-phosphatase, and PEPCK expressions were not or only slightly affected. Thus, SREBP-1 is not absolutely necessary for the hepatic Akt-mediated hypoglycemic effect. In contrast, myr-Akt-induced hypertriglyceridemia and hepatic triglyceride accumulation are mediated by both Akt-induced SREBP-1 expression and a mechanism involving fatty acid synthesis independent of SREBP-1.<\/jats:p>","DOI":"10.2337\/diabetes.52.12.2905","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"2905-2913","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":157,"title":["Hepatic Akt Activation Induces Marked Hypoglycemia, Hepatomegaly, and Hypertriglyceridemia With Sterol Regulatory Element Binding Protein Involvement"],"prefix":"10.2337","volume":"52","author":[{"given":"Hiraku","family":"Ono","sequence":"first","affiliation":[{"name":"Institute for Adult Diseases, Asahi Life Foundation, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Shimano","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba City, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Katagiri","sequence":"additional","affiliation":[{"name":"Division of Molecular Metabolism and Diabetes, Department of Internal Medicine, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Yahagi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Sakoda","sequence":"additional","affiliation":[{"name":"Institute for Adult Diseases, Asahi Life Foundation, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Onishi","sequence":"additional","affiliation":[{"name":"Institute for Adult Diseases, Asahi Life Foundation, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonobu","family":"Anai","sequence":"additional","affiliation":[{"name":"Institute for Adult Diseases, Asahi Life Foundation, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehide","family":"Ogihara","sequence":"additional","affiliation":[{"name":"Division of Molecular Metabolism and Diabetes, Department of Internal Medicine, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Fujishiro","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia Y.I.","family":"Viana","sequence":"additional","affiliation":[{"name":"Research Center of Health, Physical Fitness and Sports, Nagoya University, Chikusa-ku, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Shojima","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Institute for Adult Diseases, Asahi Life Foundation, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Yamada","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba City, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitomo","family":"Oka","sequence":"additional","affiliation":[{"name":"Division of Molecular Metabolism and Diabetes, Department of Internal Medicine, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoichiro","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031207071767300_R1","doi-asserted-by":"crossref","unstructured":"Saltiel AR, Kahn CR: Insulin signalling and the regulation of glucose and lipid metabolism. Nature\u2008414: 799\u2013806,2001","DOI":"10.1038\/414799a"},{"key":"2022031207071767300_R2","doi-asserted-by":"crossref","unstructured":"Whiteman EL, Cho H, Birnbaum MJ: Role of Akt\/protein kinase B in metabolism. Trends Endocrinol Metab\u200813: 444\u2013451,2002","DOI":"10.1016\/S1043-2760(02)00662-8"},{"key":"2022031207071767300_R3","doi-asserted-by":"crossref","unstructured":"Miyake K, Ogawa W, Matsumoto M, Nakamura T, Sakaue H, Kasuga M: Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. J Clin Invest\u2008110: 1483\u20131491,2002","DOI":"10.1172\/JCI0215880"},{"key":"2022031207071767300_R4","doi-asserted-by":"crossref","unstructured":"Czech MP, Corvera S: Signaling mechanisms that regulate glucose transport. J Biol Chem\u2008274: 1865\u20131868,1999","DOI":"10.1074\/jbc.274.4.1865"},{"key":"2022031207071767300_R5","doi-asserted-by":"crossref","unstructured":"Pessin JE, Saltiel AR: Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest\u2008106: 165\u2013169,2000","DOI":"10.1172\/JCI10582"},{"key":"2022031207071767300_R6","doi-asserted-by":"crossref","unstructured":"Calera MR, Martinez C, Liu H, Jack AK, Birnbaum MJ, Pilch PF: Insulin increases the association of Akt-2 with Glut4-containing vesicles. J Biol Chem\u2008273: 7201\u20137204,1998","DOI":"10.1074\/jbc.273.13.7201"},{"key":"2022031207071767300_R7","doi-asserted-by":"crossref","unstructured":"Kohn AD, Summers SA, Birnbaum MJ, Roth RA: Expression of a constitutively active Akt Ser\/Thr kinase in 3T3\u2013L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem\u2008271: 31372\u201331378,1996","DOI":"10.1074\/jbc.271.49.31372"},{"key":"2022031207071767300_R8","doi-asserted-by":"crossref","unstructured":"Tanti JF, Grillo S, Gremeaux T, Coffer PJ, Van Obberghen E, Le Marchand-Brustel Y: Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology\u2008138: 2005\u20132010,1997","DOI":"10.1210\/endo.138.5.5136"},{"key":"2022031207071767300_R9","doi-asserted-by":"crossref","unstructured":"Hajduch E, Alessi DR, Hemmings BA, Hundal HS: Constitutive activation of protein kinase B \u03b1 by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells. Diabetes\u200847: 1006\u20131013,1998","DOI":"10.2337\/diabetes.47.7.1006"},{"key":"2022031207071767300_R10","doi-asserted-by":"crossref","unstructured":"Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ: Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science\u2008292: 1728\u20131731,2001","DOI":"10.1126\/science.292.5522.1728"},{"key":"2022031207071767300_R11","doi-asserted-by":"crossref","unstructured":"O\u2019Brien RM, Granner DK: Regulation of gene expression by insulin. Physiol Rev\u200876: 1109\u20131161,1996","DOI":"10.1152\/physrev.1996.76.4.1109"},{"key":"2022031207071767300_R12","doi-asserted-by":"crossref","unstructured":"Chen D, Fucini RV, Olson AL, Hemmings BA, Pessin JE: Osmotic shock inhibits insulin signaling by maintaining Akt\/protein kinase B in an inactive dephosphorylated state. Mol Cell Biol\u200819: 4684\u20134694,1999","DOI":"10.1128\/MCB.19.7.4684"},{"key":"2022031207071767300_R13","doi-asserted-by":"crossref","unstructured":"Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature\u2008378: 785\u2013789,1995","DOI":"10.1038\/378785a0"},{"key":"2022031207071767300_R14","doi-asserted-by":"crossref","unstructured":"van Weeren PC, de Bruyn KM, de Vries-Smits AM, van Lint J, Burgering BM: Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation: characterization of dominant-negative mutant of PKB. J Biol Chem\u2008273: 13150\u201313156,1998","DOI":"10.1074\/jbc.273.21.13150"},{"key":"2022031207071767300_R15","doi-asserted-by":"crossref","unstructured":"Fleischmann M, Iynedjian PB: Regulation of sterol regulatory-element binding protein 1 gene expression in liver: role of insulin and protein kinase B\/cAkt. Biochem J\u2008349: 13\u201317,2000","DOI":"10.1042\/bj3490013"},{"key":"2022031207071767300_R16","doi-asserted-by":"crossref","unstructured":"Horton JD, Bashmakov Y, Shimomura I, Shimano H: Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc Natl Acad Sci U S A\u200895: 5987\u20135992,1998","DOI":"10.1073\/pnas.95.11.5987"},{"key":"2022031207071767300_R17","doi-asserted-by":"crossref","unstructured":"Osborne TF: Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J Biol Chem\u2008275: 32379\u201332382,2000","DOI":"10.1074\/jbc.R000017200"},{"key":"2022031207071767300_R18","doi-asserted-by":"crossref","unstructured":"Azzout-Marniche D, Becard D, Guichard C, Foretz M, Ferre P, Foufelle F: Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes. Biochem J\u2008350: 389\u2013393,2000","DOI":"10.1042\/bj3500389"},{"key":"2022031207071767300_R19","doi-asserted-by":"crossref","unstructured":"Becard D, Hainault I, Azzout-Marniche D, Bertry-Coussot L, Ferre P, Foufelle F: Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice. Diabetes\u200850: 2425\u20132430,2001","DOI":"10.2337\/diabetes.50.11.2425"},{"key":"2022031207071767300_R20","doi-asserted-by":"crossref","unstructured":"Foretz M, Pacot C, Dugail I, Lemarchand P, Guichard C, Le Liepvre X, Berthelier-Lubrano C, Spiegelman B, Kim JB, Ferre P, Foufelle F: ADD1\/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol\u200819: 3760\u20133768,1999","DOI":"10.1128\/MCB.19.5.3760"},{"key":"2022031207071767300_R21","doi-asserted-by":"crossref","unstructured":"Foretz M, Guichard C, Ferre P, Foufelle F: Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci U S A\u200896: 12737\u201312742,1999","DOI":"10.1073\/pnas.96.22.12737"},{"key":"2022031207071767300_R22","doi-asserted-by":"crossref","unstructured":"Chakravarty K, Leahy P, Becard D, Hakimi P, Foretz M, Ferre P, Foufelle F, Hanson RW: Sterol regulatory element-binding protein-1c mimics the negative effect of insulin on phosphoenolpyruvate carboxykinase (GTP) gene transcription. J Biol Chem\u2008276: 34816\u201334823,2001","DOI":"10.1074\/jbc.M103310200"},{"key":"2022031207071767300_R23","doi-asserted-by":"crossref","unstructured":"Shimomura I, Shimano H, Korn BS, Bashmakov Y, Horton JD: Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem\u2008273: 35299\u201335306,1998","DOI":"10.1074\/jbc.273.52.35299"},{"key":"2022031207071767300_R24","doi-asserted-by":"crossref","unstructured":"Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL: Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest\u200898: 1575\u20131584,1996","DOI":"10.1172\/JCI118951"},{"key":"2022031207071767300_R25","doi-asserted-by":"crossref","unstructured":"Yamada T, Katagiri H, Asano T, Inukai K, Tsuru M, Kodama T, Kikuchi M, Oka Y: 3-phosphoinositide-dependent protein kinase 1, an Akt1 kinase, is involved in dephosphorylation of Thr-308 of Akt1 in Chinese hamster ovary cells. J Biol Chem\u2008276: 5339\u20135345,2001","DOI":"10.1074\/jbc.M005685200"},{"key":"2022031207071767300_R26","doi-asserted-by":"crossref","unstructured":"Ono H, Katagiri H, Funaki M, Anai M, Inukai K, Fukushima Y, Sakoda H, Ogihara T, Onishi Y, Fujishiro M, Kikuchi M, Oka Y, Asano T: Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3\u2013L1 adipocytes. Mol Endocrinol\u200815: 1411\u20131422,2001","DOI":"10.1210\/mend.15.8.0684"},{"key":"2022031207071767300_R27","doi-asserted-by":"crossref","unstructured":"Sakoda H, Ogihara T, Anai M, Funaki M, Inukai K, Katagiri H, Fukushima Y, Onishi Y, Ono H, Fujishiro M, Kikuchi M, Oka Y, Asano T: Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes\u200849: 1700\u20131708,2000","DOI":"10.2337\/diabetes.49.10.1700"},{"key":"2022031207071767300_R28","doi-asserted-by":"crossref","unstructured":"Shimano H, Shimomura I, Hammer RE, Herz J, Goldstein JL, Brown MS, Horton JD: Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J Clin Invest\u2008100: 2115\u20132124,1997","DOI":"10.1172\/JCI119746"},{"key":"2022031207071767300_R29","doi-asserted-by":"crossref","unstructured":"Bucolo G, David H: Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem\u200819: 476\u2013482,1973","DOI":"10.1093\/clinchem\/19.5.476"},{"key":"2022031207071767300_R30","doi-asserted-by":"crossref","unstructured":"Allain CC, Poon LS, Chan CS, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem\u200820: 470\u2013475,1974","DOI":"10.1093\/clinchem\/20.4.470"},{"key":"2022031207071767300_R31","doi-asserted-by":"crossref","unstructured":"Folch J, Lees M, Stanley GHS: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem\u2008226: 497\u2013509,1957","DOI":"10.1016\/S0021-9258(18)64849-5"},{"key":"2022031207071767300_R32","doi-asserted-by":"crossref","unstructured":"Bergmeyer HU, Bergmeyer J, Grassl M: Methods of Enzymatic Analysis. 3rd ed. Hoboken, NJ, Wiley,1984, p. 11\u201318","DOI":"10.1016\/B978-0-12-395630-9.50008-6"},{"key":"2022031207071767300_R33","doi-asserted-by":"crossref","unstructured":"Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS: Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest\u200899: 838\u2013845,1997","DOI":"10.1172\/JCI119247"},{"key":"2022031207071767300_R34","doi-asserted-by":"crossref","unstructured":"Sheng Z, Otani H, Brown MS, Goldstein JL: Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver. Proc Natl Acad Sci U S A\u200892: 935\u2013938,1995","DOI":"10.1073\/pnas.92.4.935"},{"key":"2022031207071767300_R35","doi-asserted-by":"crossref","unstructured":"Shimomura I, Bashmakov Y, Ikemoto S, Horton JD, Brown MS, Goldstein JL: Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci U S A\u200896: 13656\u201313661,1999","DOI":"10.1073\/pnas.96.24.13656"},{"key":"2022031207071767300_R36","doi-asserted-by":"crossref","unstructured":"Kim JB, Sarraf P, Wright M, Yao KM, Mueller E, Solanes G, Lowell BB, Spiegelman BM: Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1\/SREBP1. J Clin Invest\u2008101: 1\u20139,1998","DOI":"10.1172\/JCI1411"},{"key":"2022031207071767300_R37","doi-asserted-by":"crossref","unstructured":"Kim JB, Spiegelman BM: ADD1\/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev\u200810: 1096\u20131107,1996","DOI":"10.1101\/gad.10.9.1096"},{"key":"2022031207071767300_R38","doi-asserted-by":"crossref","unstructured":"Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL: Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest\u200899: 846\u2013854,1997","DOI":"10.1172\/JCI119248"},{"key":"2022031207071767300_R39","doi-asserted-by":"crossref","unstructured":"Condorelli G, Drusco A, Stassi G, Bellacosa A, Roncarati R, Iaccarino G, Russo MA, Gu Y, Dalton N, Chung C, Latronico MV, Napoli C, Sadoshima J, Croce CM, Ross J Jr: Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A\u200899: 12333\u201312338,2002","DOI":"10.1073\/pnas.172376399"},{"key":"2022031207071767300_R40","doi-asserted-by":"crossref","unstructured":"Matsui T, Li L, Wu JC, Cook SA, Nagoshi T, Picard MH, Liao R, Rosenzweig A: Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem\u2008277: 22896\u201322901,2002","DOI":"10.1074\/jbc.M200347200"},{"key":"2022031207071767300_R41","doi-asserted-by":"crossref","unstructured":"Shioi T, McMullen JR, Kang PM, Douglas PS, Obata T, Franke TF, Cantley LC, Izumo S: Akt\/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol\u200822: 2799\u20132809,2002","DOI":"10.1128\/MCB.22.8.2799-2809.2002"},{"key":"2022031207071767300_R42","doi-asserted-by":"crossref","unstructured":"Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, Polonsky KS, Naji A, Birnbaum MJ: Regulation of pancreatic beta-cell growth and survival by the serine\/threonine protein kinase Akt1\/PKBalpha. Nat Med\u20087: 1133\u20131137,2001","DOI":"10.1038\/nm1001-1133"},{"key":"2022031207071767300_R43","doi-asserted-by":"crossref","unstructured":"Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA: Islet beta cell expression of constitutively active Akt1\/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest\u2008108: 1631\u20131638,2001","DOI":"10.1172\/JCI200113785"},{"key":"2022031207071767300_R44","doi-asserted-by":"crossref","unstructured":"O\u2019Brien RM, Granner DK: Regulation of gene expression by insulin. Biochem J\u2008278: 609\u2013619,1991","DOI":"10.1042\/bj2780609"},{"key":"2022031207071767300_R45","doi-asserted-by":"crossref","unstructured":"Nakae J, Kitamura T, Silver DL, Accili D: The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest\u2008108: 1359\u20131367,2001","DOI":"10.1172\/JCI200112876"},{"key":"2022031207071767300_R46","doi-asserted-by":"crossref","unstructured":"Schmoll D, Walker KS, Alessi DR, Grempler R, Burchell A, Guo S, Walther R, Unterman TG: Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR: evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity. J Biol Chem\u2008275: 36324\u201336333,2000","DOI":"10.1074\/jbc.M003616200"},{"key":"2022031207071767300_R47","doi-asserted-by":"crossref","unstructured":"Lochhead PA, Coghlan M, Rice SQ, Sutherland C: Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression. Diabetes\u200850: 937\u2013946,2001","DOI":"10.2337\/diabetes.50.5.937"},{"key":"2022031207071767300_R48","doi-asserted-by":"crossref","unstructured":"Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell\u200896: 857\u2013868,1999","DOI":"10.1016\/S0092-8674(00)80595-4"},{"key":"2022031207071767300_R49","doi-asserted-by":"crossref","unstructured":"Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, Burgering BM: Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature\u2008398: 630\u2013634,1999","DOI":"10.1038\/19328"},{"key":"2022031207071767300_R50","doi-asserted-by":"crossref","unstructured":"Doiron B, Cuif MH, Kahn A, Diaz-Guerra MJ: Respective roles of glucose, fructose, and insulin in the regulation of the liver-specific pyruvate kinase gene promoter. J Biol Chem\u2008269: 10213\u201310216,1994","DOI":"10.1016\/S0021-9258(17)34047-4"},{"key":"2022031207071767300_R51","doi-asserted-by":"crossref","unstructured":"Lefrancois-Martinez AM, Diaz-Guerra MJ, Vallet V, Kahn A, Antoine B: Glucose-dependent regulation of the L-pyruvate kinase gene in a hepatoma cell line is independent of insulin and cyclic AMP. Faseb J\u20088: 89\u201396,1994","DOI":"10.1096\/fasebj.8.1.8299894"},{"key":"2022031207071767300_R52","doi-asserted-by":"crossref","unstructured":"Decaux JF, Antoine B, Kahn A: Regulation of the expression of the L-type pyruvate kinase gene in adult rat hepatocytes in primary culture. J Biol Chem\u2008264: 11584\u201311590,1989","DOI":"10.1016\/S0021-9258(18)80103-X"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/52\/12\/2905\/372197\/db1203002905.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/52\/12\/2905\/372197\/db1203002905.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:16:34Z","timestamp":1667405794000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/52\/12\/2905\/11089\/Hepatic-Akt-Activation-Induces-Marked-Hypoglycemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,1]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.52.12.2905","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,1]]}}}